OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
FDA's plan to establish pharmacogenomic policies spurs concerns among manufacturers, particularly in regard to how the policies will affect new-drug testing and approval.